Details for New Drug Application (NDA): 050091
✉ Email this page to a colleague
NDA 050091 describes CHLOROPTIC, which is a drug marketed by Allergan and is included in three NDAs. Additional details are available on the CHLOROPTIC profile page.
The generic ingredient in CHLOROPTIC is chloramphenicol; prednisolone. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; prednisolone profile page.
The generic ingredient in CHLOROPTIC is chloramphenicol; prednisolone. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; prednisolone profile page.
Summary for 050091
| Tradename: | CHLOROPTIC |
| Applicant: | Allergan |
| Ingredient: | chloramphenicol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050091
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
